Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-30 Sale |
2023-03-31 2:40 pm |
Vir Biotechnology Inc. | VIR | HANLY ANN M. Chief Technology Officer |
2,627 | $22.77 | $59,817 | 114,588 (Indirect Direct) |
View |
| 2023-03-08 Sale |
2023-03-09 2:36 pm |
Vir Biotechnology Inc. | VIR | SATO VICKI L Director |
17,935 | $22.59 | $405,062 | 1,327,324 (Direct) |
View |
| 2023-03-03 Sale |
2023-03-07 2:04 pm |
Vir Biotechnology Inc. | VIR | Friedl-Naderer Johanna EVP & Chief Operating Officer |
1,482 | $22.82 | $33,819 | 148,518 (Direct) |
View |
| 2023-03-01 Purchase |
2023-03-02 4:27 pm |
Vir Biotechnology Inc. | VIR | Sigal Charles Elliott Director |
2,500 | $22.73 | $56,816 | 19,779 (Indirect Direct) |
View |
| 2023-02-27 Sale |
2023-02-28 4:39 pm |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
10,320 | $23.08 | $238,170 | 188,000 (Direct) |
View |
| 2023-02-23 Sale |
2023-02-24 8:36 pm |
Vir Biotechnology Inc. | VIR | Horn Howard CFO |
2,248 | $25.97 | $58,387 | 230,712 (Direct) |
View |
| 2023-02-23 Sale |
2023-02-24 8:35 pm |
Vir Biotechnology Inc. | VIR | HANLY ANN M. Chief Technology Officer |
2,302 | $25.97 | $59,790 | 172,215 (Indirect Direct) |
View |
| 2023-02-23 Sale |
2023-02-24 8:34 pm |
Vir Biotechnology Inc. | VIR | SCANGOS GEORGE A President and CEO |
27,750 | $24.53 | $680,747 | 5,759,638 (Indirect Direct) |
View |
| 2023-02-23 Sale |
2023-02-24 8:29 pm |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
2,878 | $25.97 | $74,750 | 268,320 (Direct) |
View |
| 2023-02-23 Sale |
2023-02-24 8:28 pm |
Vir Biotechnology Inc. | VIR | Rice Steven J. Chief Administrative Officer |
1,795 | $25.97 | $46,622 | 154,414 (Direct) |
View |
| 2023-02-21 Sale |
2023-02-23 9:00 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
74,477 | $28.43 | $2,117,336 | 18,319,938 (Indirect) |
View |
| 2023-02-17 Sale |
2023-02-21 7:29 pm |
Vir Biotechnology Inc. | VIR | SCANGOS GEORGE A President and CEO |
27,750 | $27.23 | $755,517 | 705,965 (Indirect Direct) |
View |
| 2023-02-17 Sale |
2023-02-21 7:25 pm |
Vir Biotechnology Inc. | VIR | Rice Steven J. Chief Administrative Officer |
1,981 | $25.29 | $50,096 | 37,209 (Direct) |
View |
| 2023-02-17 Sale |
2023-02-21 7:24 pm |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
2,802 | $25.29 | $70,857 | 141,198 (Direct) |
View |
| 2023-02-17 Sale |
2023-02-21 7:22 pm |
Vir Biotechnology Inc. | VIR | Horn Howard CFO |
2,424 | $25.29 | $61,298 | 232,960 (Direct) |
View |
| 2023-02-15 Sale |
2023-02-17 9:00 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
38,964 | $26.75 | $1,042,384 | 18,394,415 (Indirect) |
View |
| 2023-02-13 Sale |
2023-02-15 9:00 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
117,957 | $26.28 | $3,099,693 | 18,433,379 (Indirect) |
View |
| 2023-02-09 Sale |
2023-02-13 9:00 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
234,271 | $26.28 | $6,156,029 | 18,551,336 (Indirect) |
View |
| 2023-02-07 Sale |
2023-02-09 9:00 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
145,422 | $28.51 | $4,146,549 | 18,785,607 (Indirect) |
View |
| 2023-02-08 Sale |
2023-02-09 11:27 am |
Vir Biotechnology Inc. | VIR | SATO VICKI L Director |
17,915 | $28.38 | $508,343 | 1,345,259 (Direct) |
View |
| 2023-02-03 Sale |
2023-02-07 9:00 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
114,035 | $30.21 | $3,444,984 | 18,931,029 (Indirect) |
View |
| 2023-02-01 Sale |
2023-02-03 9:00 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
148,635 | $29.42 | $4,372,175 | 19,045,064 (Indirect) |
View |
| 2023-01-30 Sale |
2023-02-01 9:00 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
152,813 | $29.46 | $4,502,337 | 19,193,699 (Indirect) |
View |
| 2023-01-23 Sale |
2023-01-25 9:00 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
36,512 | $28.34 | $1,034,707 | 19,346,512 (Indirect) |
View |
| 2023-01-24 Sale |
2023-01-25 8:01 pm |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
30,000 | $30 | $900,057 | 195,111 (Direct) |
View |
| 2023-01-19 Sale |
2023-01-23 9:00 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
214,197 | $27.13 | $5,811,411 | 19,383,024 (Indirect) |
View |
| 2023-01-17 Sale |
2023-01-19 9:00 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
190,839 | $26.28 | $5,015,158 | 19,597,221 (Indirect) |
View |
| 2023-01-12 Sale |
2023-01-17 9:00 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
211,678 | $26.58 | $5,625,878 | 19,788,060 (Indirect) |
View |
| 2023-01-10 Sale |
2023-01-12 9:00 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
149,640 | $26.32 | $3,938,493 | 19,999,738 (Indirect) |
View |
| 2023-01-09 Sale |
2023-01-11 11:40 am |
Vir Biotechnology Inc. | VIR | SATO VICKI L Director |
17,915 | $25.83 | $462,784 | 1,363,174 (Direct) |
View |
| 2023-01-06 Sale |
2023-01-10 9:00 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
100,980 | $26.03 | $2,628,972 | 20,149,378 (Indirect) |
View |
| 2023-01-05 Purchase |
2023-01-09 11:51 am |
Vir Biotechnology Inc. | VIR | Sigal Charles Elliott Director |
2,500 | $24.96 | $62,396 | 17,279 (Indirect Direct) |
View |
| 2023-01-03 Sale |
2023-01-05 9:00 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
9,177 | $25.57 | $234,613 | 20,250,358 (Indirect) |
View |
| 2023-01-03 Purchase |
2023-01-05 5:00 pm |
Vir Biotechnology Inc. | VIR | Sigal Charles Elliott Director |
5,000 | $25.43 | $127,129 | 14,779 (Indirect Direct) |
View |
| 2022-12-29 Sale |
2023-01-03 9:00 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
44,169 | $25.55 | $1,128,461 | 20,259,535 (Indirect) |
View |
| 2022-12-27 Sale |
2022-12-29 9:00 pm |
Vir Biotechnology Inc. | VIR | SVF Endurance (Cayman) Ltd SB INVESTMENT ADVISERS (UK) LTD SOFTBANK VISION FUND (AIV M1) L.P. 10% Owner |
6,850 | $25.59 | $175,304 | 20,303,704 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-27 Option Award |
2023-03-29 5:49 pm |
N/A 2033-03-26 |
Vir Biotechnology Inc. | VIR | Lee Sung Chief Financial Officer |
199,500 | $0 | 199,500 (Direct) |
View |
| 2023-02-22 Option Award |
2023-02-24 8:35 pm |
N/A 2033-02-21 |
Vir Biotechnology Inc. | VIR | HANLY ANN M. Chief Technology Officer |
92,500 | $0 | 172,215 (Direct) |
View |
| 2023-02-22 Option Award |
2023-02-24 8:29 pm |
N/A 2033-02-21 |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
130,000 | $0 | 268,320 (Direct) |
View |
| 2023-02-22 Option Award |
2023-02-24 8:28 pm |
N/A 2033-02-21 |
Vir Biotechnology Inc. | VIR | Rice Steven J. Chief Administrative Officer |
119,000 | $0 | 154,414 (Direct) |
View |
| 2023-02-22 Option Award |
2023-02-24 8:27 pm |
N/A 2033-02-21 |
Vir Biotechnology Inc. | VIR | Friedl-Naderer Johanna EVP & Chief Operating Officer |
130,000 | $0 | 220,000 (Direct) |
View |
| 2022-12-21 Other |
2023-02-21 7:29 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | SCANGOS GEORGE A President and CEO |
114,914 | $0 | 705,965 (Indirect) |
View |
| 2023-01-24 Exercise |
2023-01-25 8:01 pm |
N/A 2028-07-19 |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
30,000 | $0 | 195,111 (Direct) |
View |
| 2023-01-24 Option Award |
2023-01-25 8:01 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
4,594 | $5.175 | 195,111 (Direct) |
View |
| 2023-01-24 Option Award |
2023-01-25 8:01 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | Pang Phillip Chief Medical Officer |
25,406 | $1.575 | 195,111 (Direct) |
View |